Dyspareunia clinical trials

Explore recruiting dyspareunia clinical trials.

Recruiting dyspareunia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dyspareunia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Esketamine As treatment for chronic pain due to endometrioSis: a RCT studY

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, Double-blind, Placebo-controlled, Proof-of-concept Phase II Trial Investigating the Effect of Valproic Acid in Women with Adenomyosis.

Bulgaria

Therapeutic exploratory (Phase II) EU CTIS Study details

The efficacy of the use of Cellular Matrix-BCT-HA (combination of autologous platelet-rich plasma and non-cross-linked hyaluronic acid) compared to local estrogen therapy (Blissel, estriol 50 micrograms/g vaginal gel) in women with genitourinary syndrome of menopause. A randomized controlled trial, with a second blind observer.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of OG-6219 in 3 Dose Levels, in Women 18 to 49 Years of Age with Moderate to Severe Endometriosis-related Pain

Bulgaria, Latvia, Germany, Italy, Czechia, Belgium +4 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection via Hysteroscopy in pelvic pain suggestive of dysmenorrhea: A Prospective, Multicenter, Double-Blind, Randomized Placebo-Controlled Study. HYSTEROXINE Study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Dyspareunia trials by city

Dyspareunia in Toronto Dyspareunia in Vancouver Dyspareunia in Montreal Dyspareunia in Calgary Dyspareunia in Edmonton Dyspareunia in Ottawa Dyspareunia in Winnipeg Dyspareunia in Quebec City Dyspareunia in Hamilton Dyspareunia in Kitchener Dyspareunia in London Dyspareunia in Halifax Dyspareunia in New York Dyspareunia in Los Angeles Dyspareunia in Chicago Dyspareunia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease